He Fei, Fan Maoxiao, Jin Yansheng, Wang Haiyan, Ding Lan, Fan Jianfeng, Gu Shuaishuai, Xu Wen
Department of Nephrology, Suzhou Wuzhong People's Hospital Suzhou 215128, Jiangsu, China.
School of Biology and Basic Medical Sciences, Soochow University RM702-2311, No. 199, Renai Road, Industrial Park, Suzhou 215123, Jiangsu, China.
Am J Transl Res. 2019 Sep 15;11(9):5879-5887. eCollection 2019.
Renal fibrosis is a critical process underlying the development progression of chronic kidney disease to end-stage renal disease, which has intrigued much attention. This study aimed to investigate the role of Sphingosine kinase 1 (SphK1) on epithelial-mesenchymal transition (EMT) in renal fibrosis and the potential regulatory mechanisms. In the present study, unilateral ureteral obstruction (UUO)-induced mouse renal fibrosis model was established. HE and Masson staining were employed to detect the pathological change and fibrous deposition in renal tissues respectively. Moreover, the expression of SphK1, EMT relative proteins including E-cadherin (E-cad), N-cadherin (N-cad) and vimentin as well as fibrosis marker protein α-smooth muscle actin (α-SMA) were measured by immunohistochemistry and Western blot, respectively. In vitro, SphK1 silencing was generated in TGF-β induced human renal tubular epithelial HK-2 cells. Immunofluorescence staining was applied to examine the expression of α-SMA, then the levels of EMT relative proteins and NF-κB signaling were measured using Western blot. The results revealed that notably tubulointerstitial damage and fibrous deposition were detected in the UUO mouse renal tissues. The expression level of E-cad and SphK1 were decreased coupled with an increase of N-cad, vimentin and α-SMA expression. Furthermore, after knockdown of SphK1 in TGF-β induced HK-2 cells, the E-cad expression was up-regulated while N-cad, vimentin and α-SMA expression were down-regulated remarkably. In addition, the expression levels of phospho-NF-κB p65 (p-NF-κB p65) and p-IκB-α were lowered significantly following SphK1 silencing. These findings indicated that the inhibition of SphK1 protected renal tubular epithelial cells against renal fibrosis, by contribution to decrease the EMT via blocking the NF-κB signaling. Therefore, SphK1 may serve as a therapeutic target in the future.
肾纤维化是慢性肾脏病发展至终末期肾病的关键过程,已引起广泛关注。本研究旨在探讨鞘氨醇激酶1(SphK1)在肾纤维化上皮-间质转化(EMT)中的作用及潜在调控机制。在本研究中,建立了单侧输尿管梗阻(UUO)诱导的小鼠肾纤维化模型。分别采用苏木精-伊红(HE)染色和Masson染色检测肾组织的病理变化和纤维沉积。此外,分别通过免疫组织化学和蛋白质免疫印迹法检测SphK1、EMT相关蛋白(包括E-钙黏蛋白(E-cad)、N-钙黏蛋白(N-cad)和波形蛋白)以及纤维化标志物蛋白α-平滑肌肌动蛋白(α-SMA)的表达。在体外,在转化生长因子-β(TGF-β)诱导的人肾小管上皮HK-2细胞中敲低SphK1。应用免疫荧光染色检测α-SMA的表达,然后用蛋白质免疫印迹法检测EMT相关蛋白水平和核因子-κB(NF-κB)信号通路水平。结果显示,在UUO小鼠肾组织中明显检测到肾小管间质损伤和纤维沉积。E-cad和SphK1的表达水平降低,同时N-cad、波形蛋白和α-SMA的表达增加。此外,在TGF-β诱导的HK-2细胞中敲低SphK1后,E-cad表达上调,而N-cad、波形蛋白和α-SMA的表达显著下调。此外,SphK1沉默后,磷酸化NF-κB p65(p-NF-κB p65)和磷酸化IκB-α的表达水平显著降低。这些发现表明,抑制SphK1可通过阻断NF-κB信号通路减少EMT,从而保护肾小管上皮细胞免受肾纤维化影响。因此,SphK1未来可能成为一个治疗靶点。